• Accueil >
  • Publications >
  • A phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease

A phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease

1 févr. 2015Movement Disorders

DOI : 10.1002/mds.26101

Auteurs

Adriana Prundean, Katia Youssov, Sandrine Humbert, Dominique Bonneau, Christophe Verny